Search

Three experiments were conducted that were designed to evaluate our ability to predict essential amino acid (EAA) needs of hybrid striped bass using the quantified lysine requirement and whole-body amino acid concentrations. In the first experiment, six diets containing various amino acid profiles were fed to triplicate groups of fish initially weighing 7.7 g per fish. At the end of the 8-week experiment, no significant differences were detected in growth rates or feed efficiencies (FE) between fish fed a practical diet containing 510 g kg−1 herring fish meal (FM) and fish fed a purified diet containing the amino acid profile of herring fish meal (CAA-FM). Growth responses of fish fed purified diets containing 100 (HSB), 110 (HSB110), 120 (HSB120) or 140 g 100 g−1 (HSB140) of the amino acid profile of hybrid striped bass whole-bodies were significantly lower than those of fish fed diet FM. In the second experiment, triplicate groups of fish (5.6 g per fish) were fed diets containing various energy : protein (E : P) ratios (34.8, 41.2, 47.5 and 53.9 kJ g−1 protein) and one of two amino acid profiles (CAA-FM and HSB120) in a 4 × 2 factorial design. Carbohydrate concentration was varied to achieve the desired energy concentrations. At the end of the 8-week experiment, weight gain and FE were significantly higher in fish fed diets formulated to simulate the amino acid profile of herring fish meal (CAA-FM) compared with fish fed diets formulated to contain 120 g 100 g−1 of the amino acid profile of hybrid striped bass whole-bodies (HSB120). Weight gain, FE and survival data indicated the optimum dietary E : P was 41.2 kJ g−1 protein. Dietary treatments in the final experiment included three amino acid profiles and four levels of lipid in a 3 × 4 incomplete factorial design. Dietary amino acid treatments included the amino acid profile of herring fish meal (CAA-FM) or 120 g 100 g−1 of the predicted EAA requirement profile for hybrid striped bass (HSB120). The amino acid profile of the remaining dietary treatment (PRED+) was similar to that of the HSB120 treatment, but contained additional threonine, isoleucine and tryptophan. Diets CAA-FM and HSB120 contained either 90, 130, 170 or 210 g kg−1 lipid, whereas diet PRED+ contained 130 g kg−1 lipid. Dietary treatments were fed for 10 weeks to triplicate groups of fish initially weighing 81.0 g per fish. Weight gain and FE were not significantly affected by dietary amino acid profile. Feed efficiency was significantly reduced in fish fed diets containing 210 g kg−1 lipid compared with fish fed diets containing 90–170 g kg−1 lipid. Intraperitoneal fat (IPF) ratio and hepatosomatic index (HSI) values generally increased as dietary lipid concentrations increased. Total liver lipid concentrations were significantly reduced in fish fed diets containing 210 g kg−1 lipid compared with those of fish fed 90–130 g kg−1 lipid. Results of this study indicate an appropriate dietary amino acid profile can be predicted for hybrid striped bass using the quantified lysine requirement and whole-body amino acid concentrations. Further, the optimum E : P appears to be 40 kJ g−1 protein. [ABSTRACT FROM AUTHOR]

Annual ryegrass baleage represents a high-quality stored forage resource for Southeastern beef producers. The objective of this project was to evaluate two baleage inoculants (Forage-Mate VS-3TM or Promote® HayDefenderTM, Cargill Animal Nutrition) and time of wrapping after baling on forage preservation characteristics of annual ryegrass baleage following a 90-d storage period. Thirty-five acres of annual ryegrass were harvested in mid-April 2017 at the EV Smith Research Center in Shorter, AL, and allowed to wilt for 24 hr prior to baling. Treatments were: 1) time of wrapping after baling [same day (S) or a two-day delay (D)], and 2) inoculant additives [control, HayDefender (H), or Forage-Mate VS-3 (VS); n = 5 bales per time × inoculant combination]. Baleage was weighed and cored for determination of nutritive value characteristics at 0-, 30- and 90-d post baling (mean 56.5% DM per bale). Data were analyzed using PROC MIXED (SAS 9.4) for a completely randomized design. Time of wrapping influenced forage DM losses, and final weight was less (P ≤ 0.05) for D than S bales (466 vs. 519 kg DM/bale, respectively). No differences were observed among inoculants in final bale weight (P = 0.4046). There was a trend (P = 0.1059) for less change in percentage DM loss for H and VS-treatments compared with the untreated control (3.7 and 3.6 vs. 5.3%, respectively). Forage DM concentrations of CP, NDF, ADF, and ADICP did not differ (P = 0.1915) among forage inoculants or time of wrapping. However, IVTD of VS-inoculated bales had less IVDMD (81.7) than C (83.9) and H (82.4) treatments (P = 0.0560). No differences were observed in bale pH among wrap time or inoculants (mean pH 4.1). There were no effects of time of wrapping or fermentation enhancers on lactic acid % (P = 0.7282), but acetic acid % was greater (P = 0.0003) for same day wrapped bales rather than two days later (1.04 and 0.87%, respectively). With increased storage time, L/A ratio increased (P < 0.0001) from 7.0 at 30-d to 13.6 at 90-d. Butryic acid % was increased (P = 0.0169) in VS-treatment (0.14%) compared with C- and H-treatments (0.04 and 0.05%, respectively). A trend for less total acid production was observed (P = 0.1031) for delayed wrapping (7.5%) compared with same day wrapping (8.0%). Results indicate that use of baleage fermentation enhancers may influence DM preservation characteristics, and changes may be more pronounced with longer storage periods. [ABSTRACT FROM AUTHOR]

At the onset of lactation, dairy cattle are at risk for developing diseases resulting from the reallocation of resources toward maintaining lactation and away from the immune system. This can lead to less powerful immune responses and increased incidences of infection. In order to continue to maintain herd health, yearly vaccinations need to be administered during the lactation period, but they may not be effective if the immune system is suppressed. The purpose of this study was to determine an ideal stage of lactation in which to administer vaccinations against infectious bovine keratoconjunctivitis. Twenty-four lactating Jersey cows were divided into 3 groups based on phase of lactation: early lactation (14-100 days in milk), mid lactation (101-200 days in milk), and late lactation (201-305 days in milk). On day 0, On day 0, serum and lacrimal secretion samples were collected, and cows were vaccinated intramuscularly against Moraxella bovis. Serum and lacrimal secretion samples were collected again on days 7 and 14. Serum IgG concentrations and lacrimal IgA concentrations against M. bovis were measured by ELISA. Data was analyzed using one-way repeated measures ANOVA with stage of lactation as the main effect. While vaccination did result in an increase in antibody concentrations against M. bovis by day 14 post-vaccination, phase of lactation had no effect on serum IgG (P=0.189) or lacrimal IgA (P=0.520) concentrations. This data indicates that the phase of lactation may not need to be taken into consideration when designing a vaccination schedule for dairy cows. Future studies using a larger sample size are warranted. [ABSTRACT FROM AUTHOR]

Reports cases of lipoatrophy occurring in diabetic patients treated by lispro insulin administered by continuous subcutaneous insulin infusion. Subjects; Risk factors; Prevalence.

CYP26 (P450RAI) catalyzes catabolic retinoic acid (RA) hydroxylation and thereby appears to play a critical role in retinoid signaling pathways during development. In this study, a quantitative competitive reverse transcriptase-polymerase chain reaction (RT-PCR) assay was developed for evaluation of CYP26 message levels in human prenatal tissues. Statistical analyses of transcription levels in 12 prenatal human brains and six prenatal human livers demonstrated good sensitivity and reproducibility. Quantitative profiles of CYP26 gene expression in early (gestational days 57-110) prenatal cephalic and hepatic tissues and comparisons with adult counterparts are reported for the first time. Prenatal cephalic tissues at days 57-67 exhibited values of 1950+/-420 (CYP26 molecules/10(6) GAPDH molecules) whereas prenatal cephalic tissues at days 105-110 exhibited values of 22300+/-4450 (CYP26 molecules/10(6) GAPDH molecules), indicating a sharp developmental increase (approximately 11-fold). Levels in human adult cephalic tissues were slightly less than the prenatal cephalic levels measured during the earliest stages of gestation and were approximately 3-fold lower than those measured in adult human hepatic tissues. Levels in human prenatal hepatic tissues at days 63-110 gestation were less than 800 (CYP26 molecules/10(6) GAPDH molecules) and did not exhibit developmental increases. Considered together, the data have strong implications for the importance of CYP26 in early development of the human brain.

To examine the mechanism by which free fatty acids (FFA) induce insulin resistance in human skeletal muscle, glycogen, glucose-6-phosphate, and intracellular glucose concentrations were measured using carbon-13 and phosphorous-31 nuclear magnetic resonance spectroscopy in seven healthy subjects before and after a hyperinsulinemic-euglycemic clamp following a five-hour infusion of either lipid/heparin or glycerol/heparin. IRS-1-associated phosphatidylinositol 3-kinase (PI 3-kinase) activity was also measured in muscle biopsy samples obtained from seven additional subjects before and after an identical protocol. Rates of insulin stimulated whole-body glucose uptake. Glucose oxidation and muscle glycogen synthesis were 50%-60% lower following the lipid infusion compared with the glycerol infusion and were associated with a approximately 90% decrease in the increment in intramuscular glucose-6-phosphate concentration, implying diminished glucose transport or phosphorylation activity. To distinguish between these two possibilities, intracellular glucose concentration was measured and found to be significantly lower in the lipid infusion studies, implying that glucose transport is the rate-controlling step. Insulin stimulation, during the glycerol infusion, resulted in a fourfold increase in PI 3-kinase activity over basal that was abolished during the lipid infusion. Taken together, these data suggest that increased concentrations of plasma FFA induce insulin resistance in humans through inhibition of glucose transport activity; this may be a consequence of decreased IRS-1-associated PI 3-kinase activity.

PCR amplifications with two sets of degenerate primers that were targeted to CYP26-specific regions were performed with cDNAs from human fetal liver and brain as templates. PCR products were purified, cloned, sequenced and analyzed with the BLAST program. Our results revealed expression of CYP26 in both human fetal liver and brain. Furthermore, human fetal CYP26 cDNA exhibited 99.2%-100% nucleotide sequence identity to its adult counterpart. Novel isoforms, that would have indicated additional CYP26 genes, were not found. A Northern blot containing poly(A+)RNAs from 43 human adult and 7 human fetal tissues was tested for CYP26 expression. We were able to detect CYP26 message in most tissues but hybridization signals varied in intensity. Highest levels of transcription were in adult liver, heart, pituitary gland, adrenal gland, placenta and regions of the brain. CYP26 expression in fetal tissues was strongest in the brain and comparable with message levels in adult tissues., (Copyright 1998 Academic Press.)

Patients with Type 1 diabetes mellitus have an increased risk of ischaemic heart disease (IHD). When diabetes is complicated by nephropathy this risk is further increased and asymptomatic IHD is common. New techniques for non-invasive cardiac evaluation are now available and one of these, Dobutamine Stress Echocardiography (DSE), was studied in subjects with Type 1 DM and nephropathy who had no evidence of IHD. DSE was performed on 18 subjects (13 male, 5 female; mean age 37.8 +/- 3.4 years), diabetes duration 23.7 +/- 1.2 years and nephropathy diagnosed for 10.9 +/- 1.3 years. There were 7 (38%) positive scans-suggesting asymptomatic IHD; 16.7% of subjects studied had a significant arrhythmia. Coronary angiography was performed in 6 of the 7 subjects with positive DSEs and was positive in only 2. These results suggest that DSE has a high rate of false positive results in Type 1 DM patients suffering from nephropathy and may limit its usefulness in these subjects.

An aggressive start-up strategy was used to initiate codigestion in two anaerobic, continuously mixed bench-top reactors at mesophilic (37 degrees C) and thermophilic (55 degrees C) conditions. The digesters were inoculated with mesophilic anaerobic sewage sludge and cattle manure and were fed a mixture of simulated municipal solid waste and biosolids in proportions that reflect U.S. production rates. The design organic loading rate was 3.1 kg volatile solids/m3/day and the retention time was 20 days. Ribosomal RNA-targeted oligonucleotide probes were used to determine the methanogenic community structure in the inocula and the digesters. Chemical analyses were performed to evaluate digester performance. The aggressive start-up strategy was successful for the thermophilic reactor, despite the use of a mesophilic inoculum. After a short start-up period (20 days), stable performance was observed with high gas production rates (1.52 m3/m3/day), high levels of methane in the biogas (59%), and substantial volatile solids (54%) and cellulose (58%) removals. In contrast, the mesophilic digester did not respond favorably to the start-up method. The concentrations of volatile fatty acids increased dramatically and pH control was difficult. After several weeks of operation, the mesophilic digester became more stable, but propionate levels remained very high. Methanogenic population dynamics correlated well with performance measures. Large fluctuations were observed in methanogenic population levels during the start-up period as volatile fatty acids accumulated and were subsequently consumed. Methanosaeta species were the most abundant methanogens in the inoculum, but their levels decreased rapidly as acetate built up. The increase in acetate levels was paralleled by an increase in Methanosarcina species abundance (up to 11.6 and 4.8% of total ribosomal RNA consisted of Methanosarcina species ribosomal RNA in mesophilic and thermophilic digesters, respectively). Methanobacteriaceae were the most abundant hydrogenotrophic methanogens in both digesters, but their levels were higher in the thermophilic digester., (Copyright 1998 John Wiley & Sons, Inc.)

The content and composition of gangliosides were examined in an experimental mouse brain tumor, EPEN, that was grown subcutaneously in the flank of the syngeneic C57BL/6J (B6) host and in the B6 severe combined immunodeficiency (SCID) host. SCID mice lack functional T- and B-lymphocytes, but have a normal complement of macrophages. The content and distribution of the brain tumor gangliosides were similar whether the tumor was grown in the immunocompetent B6 host or in the B6-SCID host. N-acetylneuraminic acid- (NeuAc) containing GM3 was the major ganglioside in the subcutaneous tumors and in the cultured EPEN cells. Significant amounts of N-glycolylneuraminic acid- (NeuGc) containing gangliosides were found in the tumor grown in both mouse hosts. NeuGc-containing gangliosides are not expressed in normal mouse brain, but are present in macrophages and serum. An extremely complex pattern of minor gangliosides was found in the subcutaneous tumors on two-dimensional, high-performance thin-layer chromatograms. Most of the minor gangliosides comigrated with those found in mouse macrophages. The results show that the absence of functional T- and B-lymphocytes does not markedly affect brain tumor ganglioside composition and suggest that NeuGc-containing gangliosides in the EPEN can be derived from tumor infiltrating host cells (mostly macrophages) and from the extracellular milieu (serum).

Autoantibodies to oxidized low density lipoprotein have been shown to be an independent predictor of the progression of carotid atherosclerosis. This study examines the relationship between low density lipoprotein fatty acid composition and autoantibodies to both malondialdehyde-modified and copper-oxidized low density lipoprotein in non-diabetic patients with (n = 17), and without (n = 18), definite evidence of previous myocardial infarction. The third group were non-insulin-dependent diabetic patients with no evidence of atherosclerosis (n = 15) and the fourth group were patients with non-insulin-dependent diabetes (n = 17) who had definite evidence of previous myocardial infarction. Fatty acids were measured by gas-liquid chromatography. Antibodies to malondialdehyde-modified low density lipoprotein and copper-oxidized low density lipoprotein were determined by an ELISA method. Autoantibodies to copper-oxidized low density lipoprotein were significantly higher in the non-diabetic patients with heart disease when compared to any other group (p < 0.05). Autoantibodies to malondialdehyde-modified low density lipoprotein were significantly higher in the non-diabetic subjects with heart disease and in both diabetic groups compared to non-diabetic subjects without coronary heart disease (p < 0.05). Linoleic acid (%) in low density lipoprotein did not differ between groups groups but arachidonic acid (%) was significantly lower in both diabetic and non-diabetic patients with coronary heart disease (p < 0.05). The diabetic patients with low antibodies had 39.6 +/- 2.2% polyunsaturated fatty acids in their low density lipoprotein while diabetic patients with high antibodies had 46.7 +/- 1.2% polyunsaturates in their low density lipoprotein (p < 0.01). This study confirms the association between antibodies to oxidized low density lipoprotein and coronary heart disease and shows raised low density lipoprotein antibody levels in diabetic patients with and without demonstrable atherosclerosis. In the diabetic patients, those with high antibody levels had high polyunsaturated fatty acid levels in their LDL suggesting a possible role for dietary intervention.

Background: Laser skin resurfacing is a very promising new treatment for solar elastosis and acne scars. The Ultrapulse carbon dioxide (CO2) laser and the SilkTouch flashscanner allow precise depth control and char-free ablation. Earlier studies have been done mainly on Caucasian skin types I and II, but very little data were available on pigmented skin., Objective: The purpose of this study is to assess the efficacy and safety of laser skin resurfacing in skin types III and IV., Methods: Thirty Asian and Hispanic patients were treated for facial rhytides and acne scars. All patients were instructed to use tretinoin cream 0.05%, hydroquinone 5%, and desonide 0.1% cream nightly for 2-4 weeks prior to the laser treatment. The Ultrapulse 5000C CO2 laser with the Truespot 3-mm collimated handpiece at the setting of 250-450 mJ per pulse, or the Silk-Touch flashscanner at the setting of 5-7 W, 0.2-second pulse duration, and 4-mm (M) spot size, was used. Patients were evaluated clinically, and global response was assessed by both clinicians and patients., Results: The facial rhytides and acne scars improved 25-50% in all patients after one laser treatment. The most common side effects were persistent erythema that resolved on the average of 6 weeks. Hyperpigmentation occurred, but was reduced with regular use of tretinoin, hydroquinone, and desonide cream both pre- and postoperatively along with use of broad spectrum sunscreen after treatments., Conclusion: Laser skin resurfacing can be used to treat facial rhytides and acne scars in skin phototypes III and IV. When proper pre- and postoperative management is implemented, the risk of dyspigmentation can be reduced.

Background: Carbon dioxide laser skin resurfacing using either ultrapulsed lasers or scanning skin lasers has evolved as an effective method of treating photodamaged skin., Objective: The purpose of this paper is to describe appropriate pre- and posttreatment regimens to ensure the optimum response to laser therapy., Methods: We describe our experiences with 30 patients treated with laser skin resurfacing using different pre- and posttreatment regimens. Patients were evaluated by physicians as regards to their responses to and recovery from laser therapy. Some patients agreed to skin biopsy and cutaneous patch testing of topically applied agents., Results: Eighty percent of patients achieved good to excellent improvement. Sixty-five percent of patients undergoing laser skin resurfacing developed contact dermatitis to several topical agents. Patch testing was negative on normal skin for contact allergy, suggesting a primary irritant reaction in laser-treated skin. Post-laser hyperpigmentation and erythema were the most noted immediate and mid-term side effects to laser resurfacing. An optimum pretreatment regime includes topical retinoids, skin lightening agents, and, immediately pretreatment, oral anti-herpes simplex medication plus oral antibiotics. An optimum posttreatment regimen includes minimizing topical therapy with the use of dilute acetic acid facial soaks. In addition, oral anti-herpes simplex medications and broad spectrum antibiotics are continued for 7 days post-laser resurfacing., Conclusion: Laser skin resurfacing is an evolving means of treating photodamaged skin. Carefully selected pre- and posttreatment regimens, ideally under dermatologic supervision, are required to obtain optimum results.

Background: The Ultrapulse carbon dioxide (CO2) laser has been shown to be a highly effective treatment for photodamaged skin including improvement of rhytides, precancerous and benign skin lesions, as well as superficial benign pigmented lesions., Objective: We describe our experiences using the Ultapulse CO2 laser in treating 100 patients with different severities of photodamaged skin., Methods: All patients had moderately or severely photodamaged skin and were selected for treatment with the Ultrapulse CO2 laser to evaluate the efficacy and toxicity of this treatment. The patients were placed on a pretreatment regimen for 2-6 weeks prior to receiving treatment with the Ultrapulse CO2 laser. Patients were evaluated for pre- and posttreatment severity of photodamage. In addition, skin surface replicas were obtained in selected patients and evaluated by computer image analysis technology., Results: At 1 month post-laser treatment, 68 patients received a moderate improvement, five patients achieved a marked improvement, and the remaining 27 patients showed minimal improvement. By 2 months post-laser treatment, 20 of the 27 patients who at 1 month showed only minimal improvement revealed a moderate to marked improvement from baseline. All the patients studied developed a transient erythema that lasted up to 6 weeks, and many of these patients showed a transient hyperpigmentation that persisted for up to 4 months., Conclusion: The Ultrapulse CO2 laser is confirmed as an effective treatment for skin resurfacing of photodamaged skin.

The microbial community structure of twenty-one single-phase and one two-phase full-scale anaerobic sewage sludge digesters was evaluated using oligonucleotide probes complementary to conserved tracts of the 16S rRNAs of phylogenetically defined groups of methanogens and sulfate-reducing bacteria. These probe results were interpreted in combination with results from traditional chemical analyses and metabolic activity assays. It was determined that methanogens in "healthy" mesophilic, single-phase sewage sludge digesters accounted for approximately 8-12% of the total community and that Methanosarcinales and Methanomicrobiales constituted the majority of the total methanogen population. Methanobacteriales and Methanococcales played a relatively minor role in the digesters. Phylogenetic groups of mesophilic, Gram-negative sulfate-reducing bacteria were consistently present at significant levels: Desulfovibrio and Desulfobulbus spp. were the dominant sulfate-reducing populations, Desulfobacter and Desulfobacterium spp. were present at lower levels, and Desulfosarcina, Desulfococcus, and Desulfobotulus spp. were absent. Sulfate reduction by one or more of these populations played a significant role in all digesters evaluated in this study. In addition, sulfate-reducing bacteria played a role in favoring methanogenesis by providing their substrates. The analysis of the two-phase digester indicated that true phase separation was not accomplished: significant levels of active methanogens were present in the first phase. It was determined that the dominant populations in the second phase were different from those in the single-phase digesters.

Two experiments were conducted to estimate the dietary choline requirement and to determine the effects of dietary choline on liver lipid deposition in juvenile hybrid striped bass (Monrone saxatilis x M. chrysops). Experimental diets contained 0.73 g total sulfur amino acids/100 g diet (0.47 g methionine + 0.26 g cyst(e)ine/100 g diet), thus meeting, but not exceeding, the requirement. Graded levels of choline bitartrate in Experiment 1 and choline chloride in Experiment 2 were added to the basal diet, resulting in eight dietary treatments in each experiment. Dietary treatments were 0, 250, 500, 1000, 2000, 4000, 6000 and 8000 mg choline/kg dry diet. Diets were fed for 12 and 10 wk in Experiments 1 and 2, respectively. Dietary choline concentrations significantly affected weight gain, feed efficiency, survival and total liver lipid concentrations in each experiment. Weight gain and feed efficiency were greatest in fish fed 500 mg choline/kg dry diet as choline bitartrate. Total liver lipid concentrations were variable but tended to be lowest in fish fed diets containing at least 2000 mg choline/kg diet. Survival was significantly lower in the group of fish fed 8000 mg choline/kg diet supplied by choline bitartrate. Weight gain and feed efficiency were greatest and total liver lipid concentration was lowest in groups of fish fed at least 500 mg choline/kg diet as choline chloride; survival was unaffected by dietary treatment. Therefore, choline chloride seems to be a better source of dietary choline than choline bitartrate and 500 mg choline/kg diet is adequate for maximum weight gain and prevention of increased liver lipid concentration in juvenile hybrid striped bass.

Two experiments were conducted to determine the dietary arginine requirement of juvenile hybrid striped bass (Morone saxatilis x M. chrysops); a third experiment evaluated the interaction of lysine and arginine. Diets in Experiments 1 and 2 were supplemented with graded concentrations of L-arginine-HCl, resulting in eight dietary treatments. Dietary arginine concentrations ranged from 1.0 to 2.4 g/100 g diet in Experiment 1 and from 0.6 to 2.0 g/100 g diet in Experiment 2. Weight gain was not affected by dietary treatments in Experiment 1. Feed efficiency was significantly affected by dietary arginine concentrations, and the data, when subjected to broken-line analysis, resulted in a requirement estimate of 1.53 +/- 0.20 g/100 g diet. Weight gain and feed efficiency were both significantly affected by dietary arginine concentrations in Experiment 2. Broken-line analyses of weight gain and feed efficiency data indicated the dietary arginine requirement to be 1.55 +/- 0.10 and 1.45 +/- 0.12 g/100 g diet, respectively. Diets in Experiment 3 contained lysine and arginine in ratios of 1:1, 1:1.5, 1:2 and 1:2.5 for the previously estimated requirements for both lysine:arginine and arginine:lysine. No differences were observed in weight gain or feed efficiency for fish fed various lysine:arginine ratios, but serum lysine was significantly different among treatment groups.

Two experiments were conducted to determine the dietary lysine requirement of juvenile hybrid striped bass (Morone saxatilis x M. chrysops). In both experiments the diets contained 35 g crude protein/100 g diet (10 g crude protein supplied by casein and gelatin and 25 g crude protein supplied by crystalline L-amino acids) and contained graded levels of L-lysine.HCl resulting in eight dietary treatments. Diets were fed to triplicate groups of fish and ranged in dietary lysine concentration from 1.2 to 2.6 g/100 g of the dry diet in Experiment 1 and from 0.8 to 2.2 g/100 g of the dry diet in Experiment 2. Weight gain and food efficiency data from Experiment 1 indicated the dietary lysine requirement to be between 1.2 and 1.4 g/100 g of the dry diet. Weight gain, food efficiency and serum lysine data from Experiment 2 confirmed the requirement to be between 1.2 and 1.4 g/100 g of the dry diet. Broken-line analysis of weight gain and food efficiency data from Experiment 2 indicated the dietary lysine requirement to be 1.4 +/- 0.2% of the dry diet, or 4.0 g/100 g of the dietary protein. Changes in the relative proportions of dietary lipid and carbohydrate between the two experiments, although maintaining similar gross energy levels, did not alter the lysine requirement estimate of juvenile hybrid striped bass.